← Back to headlines
Goldman Sachs trims Insulet price target despite strong Q1
Goldman Sachs has lowered its price target for Insulet Corporation (PODD), even after the company reported strong first-quarter results.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
